{"id":"https://openalex.org/W4388047798","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","title":"395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM\u2122) adoptive cell therapy (ACT) T cells","display_name":"395 Enhancement of bispecific T cell engagers (bispecific TCE) killing potency in AML with the neximmune artificial immune modulation (AIM\u2122) adoptive cell therapy (ACT) T cells","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047798","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0395"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0395","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/443.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/443.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031755873","display_name":"Ruipeng Wang","orcid":"https://orcid.org/0000-0002-1003-1420","observed_orcids":["https://orcid.org/0000-0002-1003-1420"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruipeng Wang","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024667876","display_name":"Mathias Oelke","orcid":"https://orcid.org/0000-0003-2253-6167","observed_orcids":["https://orcid.org/0000-0003-2253-6167"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mathias Oelke","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104185484","display_name":"Shweta Jain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shweta Jain","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101496879","display_name":"Sojung Kim","orcid":"https://orcid.org/0000-0002-8244-1613","observed_orcids":["https://orcid.org/0000-0002-8244-1613"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sojung Kim","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086237607","display_name":"Jack A. Ragheb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Ragheb","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101415013","display_name":"Adam R. Parks","orcid":"https://orcid.org/0009-0009-8646-0334","observed_orcids":["https://orcid.org/0009-0009-8646-0334"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Parks","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100431359","display_name":"Rui Wang","orcid":"https://orcid.org/0009-0004-8149-3173","observed_orcids":["https://orcid.org/0009-0004-8149-3173","https://orcid.org/0000-0003-1156-0508"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Wang","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Charles Reed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Reed","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104189849","display_name":"Brian Alvarez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Alvarez","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055075571","display_name":"Jerome B. Zeldis","orcid":"https://orcid.org/0000-0002-0184-0672","observed_orcids":["https://orcid.org/0000-0002-0184-0672"]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerome Zeldis","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026048069","display_name":"Daniel P. Bednarik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115701","display_name":"NexImmune (United States)","ror":"https://ror.org/02mczt252","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Bednarik","raw_affiliation_strings":["NeImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NeImmune, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210115701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210115701"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A443","last_page":"A443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.33059999346733093,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.33059999346733093,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2759000062942505,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.10700000077486038,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9860000014305115},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cd123","display_name":"CD123","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cd33","display_name":"CD33","score":0.9950000047683716},{"id":"https://openalex.org/keywords/siglec-6","display_name":"Siglec-6","score":0.9919999837875366},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.7310000061988831},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6650000214576721},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8610000014305115}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5910067558288574},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5804314613342285},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5381956696510315},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5012495517730713},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.4621840715408325},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4528130888938904},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43128615617752075},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3976101279258728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35735616087913513},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2974277138710022},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2599049210548401},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.11210444569587708},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10867145657539368}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0395","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/443.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:ff3b989524db42ddac49ccdbdaf2aeaa","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/ff3b989524db42ddac49ccdbdaf2aeaa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0395","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0395","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/443.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047798.pdf","grobid_xml":"https://content.openalex.org/works/W4388047798.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7138255624","https://openalex.org/W7143362111","https://openalex.org/W4283316658","https://openalex.org/W4389242939","https://openalex.org/W7223308717","https://openalex.org/W4307836527","https://openalex.org/W4200106780","https://openalex.org/W2987804651","https://openalex.org/W4401816644","https://openalex.org/W2886576964"],"abstract_inverted_index":{"Background":[0],"Bispecific":[1,15,33],"TCEs":[2,34,106,318],"are":[3],"a":[4,39,43,372,395],"new":[5],"class":[6],"of":[7,13,42,49,92,148,178,202,214,217,240,316,346,371],"immunotherapeutic":[8],"molecules":[9,17],"for":[10,121,340],"the":[11,19,47,90,93,146,165,189,194,212,293,313,325,329,334,338,347,369],"treatment":[12,78],"cancer.":[14],"TCE":[16,51,77,150,158,175,192,290,376],"enhance":[18,328],"patient\u2019s":[20],"immune":[21],"response":[22],"to":[23,29,156,198,235,266,327,352],"tumors":[24],"by":[25],"retargeting":[26],"T":[27,64,83,139,170,186,218,228,254,392],"cells":[28,84,219,229,255,393],"tumor":[30,123,168],"cells.":[31,140,287],"However,":[32],"show":[35],"rapid":[36],"clearance":[37],"with":[38,79,128,164,184,303,324,379],"serum":[40],"half-life":[41],"few":[44],"hours,":[45],"therefore":[46],"administration":[48],"bispecific":[50,76,94,105,149,157,174,221,244,289,317,348,375],"often":[52],"requires":[53],"high":[54,341],"doses":[55],"and":[56,114,116,137,151,225,252,319,343],"continuous":[57,344],"intravenous":[58],"infusion,":[59],"which":[60],"can":[61,87,263],"result":[62],"in":[63,119,126,204,233,292,309,356,365,377,394],"cell":[65,124,171,180,207,268,272,276,301],"exhaustion":[66],"at":[67,333],"higher":[68],"doses.":[69],"Methods":[70],"Here":[71],"we":[72,99,210,358],"evaluated":[73],"if":[74],"combining":[75],"NexImmunes":[80],"AIM":[81,131,152,237,261,283,304,322,385],"ACT":[82,132,153,262,284,323,386],"(AIM":[85],"ACT)":[86],"further":[88],"improve":[89],"effect":[91,196,315,331],"TCE.":[95,349],"For":[96],"this":[97],"study":[98,367],"have":[100],"generated":[101],"5":[102],"AML":[103,179],"specific":[104,191,374,384],"targeting":[107],"FLT3":[108],"(two":[109],"different":[110,215],"molecules),":[111],"CD123,":[112],"CD33":[113],"Siglec-6":[115,190],"tested":[117,206],"them":[118],"vitro":[120,310],"AML-specific":[122,130,260],"killing":[125,177,242,277,302],"combination":[127,147,370,378],"either":[129,380],"or":[133,387],"non-specific":[134,169,249],"bulk":[135,250,390],"CD4":[136,224,251],"CD8":[138,185,226,253],"Results":[141],"We":[142],"present":[143,360],"data":[144,361],"that":[145,160],"is":[154],"superior":[155],"monotreatment":[159],"relies":[161],"on":[162],"engaging":[163],"host":[166],"endogenous":[167],"repertoire.":[172],"All":[173],"mediated":[176],"lines,":[181],"when":[182,281],"combined":[183],"cells,":[187],"although":[188],"had":[193,256],"lowest":[195],"due":[197],"low":[199],"surface":[200],"expression":[201],"Siglec6":[203],"these":[205,308],"lines.":[208],"Specifically,":[209],"interrogated":[211],"potency":[213,258],"types":[216],"as":[220,285],"effectors":[222],"including":[223],"control":[227],"from":[230,362],"healthy":[231],"volunteers":[232],"comparison":[234],"our":[236,320,354,363,381],"ACT.":[238,305],"Analysis":[239],"TCR-mediated":[241],"(without":[243],"TCE)":[245],"showed":[246],"that,":[247],"both":[248],"little":[257],"while":[259,332],"mediate":[264],"effector":[265,286],"target":[267,271,275,300],"ratio":[269],"dependent":[270],"killing.":[273],"Overall":[274],"was":[278],"most":[279],"efficient":[280],"using":[282],"Notably,":[288],"concentrations":[291],"picomolar":[294],"range":[295],"achieved":[296],"greater":[297],"than":[298],"80%":[299],"Conclusions":[306],"Together":[307],"studies":[311],"demonstrate":[312],"synergistic":[314],"multi-antigen-specific":[321],"potential":[326],"therapeutic":[330],"same":[335],"time":[336],"lowering":[337],"requirement":[339],"dose":[342],"infusion":[345],"In":[350],"addition,":[351],"validate":[353],"findings":[355],"vivo":[357,366],"will":[359],"ongoing":[364],"evaluating":[368],"CD123":[373],"multi-AML":[382],"antigen-peptide":[383],"freshly":[388],"isolated":[389],"CD8+":[391],"THP-1/NSG":[396],"humanized":[397],"mouse":[398],"model.":[399]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}